FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Novelties in dosage form design of the cardiovascular drugs

Farmaceutsko-tehnološki aspekti savremenih kardiovaskularnih lekova

Thumbnail
2008
1146.pdf (383.7Kb)
Authors
Ibrić, Svetlana
Parojčić, Jelena
Jakšić, Ivana
Đurić, Zorica
Article (Published version)
Metadata
Show full item record
Abstract
Contemporary trends in dosage form development for cardiovascular therapeutics are orientated toward rationalization and individualization of drug administration with the achievement of good compliance. Therefore, novelties in formulation development of cardiovascular drugs are directed towards the modified drug delivery systems. There is a number and variety of new technologies employed with this respect. In the present paper, and overview of the most important technologies applied in commercially available drug products within the group of cardiovascular drugs is given, such as extended release tablets/capsules, multiparticulate drug delivery systems, pulsatile drug delivery and OrosTM technology.
Savremen farmaceutsko-tehnološki pristup formulaciji preparata u terapiji kardiovaskularnih oboljenja vezan je, pre svega, za individualizaciju i racionalizaciju terapije uz obezbeđenje dobre prihvatljivosti od strane pacijenta i smanjenje neželjenih efekata. U skladu sa tim, novine u formulaciji farmaceutskih oblika sa kardiovaskularnim lekovima odnose se, uglavnom, na razvoj novih, 'naprednih' terapijskih sistema, tj. preparata sa modifikovanim oslobađanjem lekovite supstance. U radu je dat je pregled tehnologija zastupljenih u komercijalno dostupnim preparatima koji se koriste u terapiji kardiovaskularnih oboljenja, s posebnim osvrtom na tablete/kapsule sa modifikovanim oslobađanjem, višečestične terapijske sisteme, preparate sa pulsnim oslobađanjem lekovite supstance i OrosTM terapijske sisteme.
Keywords:
cardiovascular drugs / tablets / capsules / drug delivery systems / modified release / lekovi u terapiji kardiovaskularnih oboljenja / modifikovano oslobađanje / tablete / kapsule / terapijski sistemi
Source:
Arhiv za farmaciju, 2008, 58, 5-6, 432-442
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd

ISSN: 0004-1963

[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_farfar_1148
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/1148
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Ibrić, Svetlana
AU  - Parojčić, Jelena
AU  - Jakšić, Ivana
AU  - Đurić, Zorica
PY  - 2008
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1148
AB  - Contemporary trends in dosage form development for cardiovascular therapeutics are orientated toward rationalization and individualization of drug administration with the achievement of good compliance. Therefore, novelties in formulation development of cardiovascular drugs are directed towards the modified drug delivery systems. There is a number and variety of new technologies employed with this respect. In the present paper, and overview of the most important technologies applied in commercially available drug products within the group of cardiovascular drugs is given, such as extended release tablets/capsules, multiparticulate drug delivery systems, pulsatile drug delivery and OrosTM technology.
AB  - Savremen farmaceutsko-tehnološki pristup formulaciji preparata u terapiji kardiovaskularnih oboljenja vezan je, pre svega, za individualizaciju i racionalizaciju terapije uz obezbeđenje dobre prihvatljivosti od strane pacijenta i smanjenje neželjenih efekata. U skladu sa tim, novine u formulaciji farmaceutskih oblika sa kardiovaskularnim lekovima odnose se, uglavnom, na razvoj novih, 'naprednih' terapijskih sistema, tj. preparata sa modifikovanim oslobađanjem lekovite supstance. U radu je dat je pregled tehnologija zastupljenih u komercijalno dostupnim preparatima koji se koriste u terapiji kardiovaskularnih oboljenja, s posebnim osvrtom na tablete/kapsule sa modifikovanim oslobađanjem, višečestične terapijske sisteme, preparate sa pulsnim oslobađanjem lekovite supstance i OrosTM terapijske sisteme.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Novelties in dosage form design of the cardiovascular drugs
T1  - Farmaceutsko-tehnološki aspekti savremenih kardiovaskularnih lekova
VL  - 58
IS  - 5-6
SP  - 432
EP  - 442
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1148
ER  - 
@article{
author = "Ibrić, Svetlana and Parojčić, Jelena and Jakšić, Ivana and Đurić, Zorica",
year = "2008",
abstract = "Contemporary trends in dosage form development for cardiovascular therapeutics are orientated toward rationalization and individualization of drug administration with the achievement of good compliance. Therefore, novelties in formulation development of cardiovascular drugs are directed towards the modified drug delivery systems. There is a number and variety of new technologies employed with this respect. In the present paper, and overview of the most important technologies applied in commercially available drug products within the group of cardiovascular drugs is given, such as extended release tablets/capsules, multiparticulate drug delivery systems, pulsatile drug delivery and OrosTM technology., Savremen farmaceutsko-tehnološki pristup formulaciji preparata u terapiji kardiovaskularnih oboljenja vezan je, pre svega, za individualizaciju i racionalizaciju terapije uz obezbeđenje dobre prihvatljivosti od strane pacijenta i smanjenje neželjenih efekata. U skladu sa tim, novine u formulaciji farmaceutskih oblika sa kardiovaskularnim lekovima odnose se, uglavnom, na razvoj novih, 'naprednih' terapijskih sistema, tj. preparata sa modifikovanim oslobađanjem lekovite supstance. U radu je dat je pregled tehnologija zastupljenih u komercijalno dostupnim preparatima koji se koriste u terapiji kardiovaskularnih oboljenja, s posebnim osvrtom na tablete/kapsule sa modifikovanim oslobađanjem, višečestične terapijske sisteme, preparate sa pulsnim oslobađanjem lekovite supstance i OrosTM terapijske sisteme.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Novelties in dosage form design of the cardiovascular drugs, Farmaceutsko-tehnološki aspekti savremenih kardiovaskularnih lekova",
volume = "58",
number = "5-6",
pages = "432-442",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1148"
}
Ibrić, S., Parojčić, J., Jakšić, I.,& Đurić, Z.. (2008). Novelties in dosage form design of the cardiovascular drugs. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 58(5-6), 432-442.
https://hdl.handle.net/21.15107/rcub_farfar_1148
Ibrić S, Parojčić J, Jakšić I, Đurić Z. Novelties in dosage form design of the cardiovascular drugs. in Arhiv za farmaciju. 2008;58(5-6):432-442.
https://hdl.handle.net/21.15107/rcub_farfar_1148 .
Ibrić, Svetlana, Parojčić, Jelena, Jakšić, Ivana, Đurić, Zorica, "Novelties in dosage form design of the cardiovascular drugs" in Arhiv za farmaciju, 58, no. 5-6 (2008):432-442,
https://hdl.handle.net/21.15107/rcub_farfar_1148 .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB